| |  | Fluence Newsletter - June 2021Day Trip this weekend, Diversity Fund update, & more | Dear Fluence community, As you may know, last month the journal Nature published the results from the landmark MAPS-sponsored Phase 3 clinical trial of MDMA-assisted therapy for PTSD. Conducted by MAPS Public Benefit Corporation, which included Fluence co-founder Dr. Ingmar Gorman and lead trainer Dr. Casey Paleos, the study’s results added further support for MDMA-assisted therapy as a potential breakthrough treatment for mental illness. As The New York Times declared, “The Psychedelic Revolution is Coming. Psychiatry May Never Be the Same.” | The results of this study and others have created a pathway for FDA approval of MDMA, psilocybin, and other psychedelic compounds for supporting and enhancing the therapeutic process, marking a major milestone for the therapeutic and psychiatric communities. This is a transformative time for psychedelic research, and we couldn’t be more excited to be with you at the forefront of it all. Read on to discover the latest news from Fluence, including upcoming courses, Fluence news and podcasts, an important update about our Diversity Fund, and more. As always, you can follow Fluence on LinkedIn, Facebook, Twitter, and Instagram to stay connected. Until next time, |  | | | Last Chance to Register: A Day Trip with Mendel KaelenDon’t miss out! Register today for our upcoming webinar, A Day Trip with Mendel Kaelen, taking place this Saturday, June 5 at 11AM EDT. The combined use of music and psychedelics is ancient and universal, yet with the rise of psychedelic therapy, many questions are emerging around the function of music and how to apply it effectively within a range of therapeutic contexts. This workshop is designed for therapists and clinicians working with music in their practice and will explore the role and application of music in psychedelic therapy. |
|
|
|
|
|
| |  | Register today for ILLUMINATING SELFJoin fellow therapists, healthcare, and wellness providers for our new writing & meditation group, Illuminating Self. With themes of love, fear, and time are woven throughout the program, this 6-session group will deepen your ability to engage more compassionately and emphatically with patients who are integrating psychedelic experiences. Wednesdays starting July 7, 2021 at 3pm ET |
|
|
|
|
|
| | |  | Explore Our Upcoming Trainings and CoursesWe’re always adding new trainings and courses, and encourage you to sign up for them as soon as possible before spots are filled. Below is a list of some of our Summer and Fall courses that are currently open for registration: |
|
|
|
|
|
| | An Announcement Regarding Our
Diversity Fund | Fluence’s Diversity Fund Scholarship Program has been active for a little over a year, allocating more than $10,500 to qualifying individuals in the period from May 2020 to April 2021. Under the guidance of Diversity Fund Manager Aja Molinar, the fund will continue to uphold Fluence’s core principle of expanding access to psychedelic-assisted psychotherapy knowledge and integration. Partial scholarships (25%-50%) are available for nearly every program Fluence offers–with some international applicants receiving up to 75% coverage in instances where the currency exchange rate is an added burden. While it is our goal to provide full scholarships in the future, the partial scholarship model works within the scope of our present funding capabilities in upholding Fluence’s principle of expanded access in aiming to serve as many individuals representing as many diverse communities as possible. For more information please see our Mission Statement and our Diversity and Inclusion policy. |
| |
|
|
|
|
| The Diversity Fund application is designed to be holistic and inclusive, and we recognize and seek to honor the variety of factors impacting one’s decision to apply for funding beyond those outlined by the Diversity Fund, including debt, having a child with a disability, etc. Ultimately, if an applicant demonstrates need and we have the funds, we will assist them. While we do offer scholarships for the weekly reading and clinical consultation groups, the majority of scholarships are allocated to those participating in our core introductory training modules ‘Psychedelic Integration: Premise and Promise’ and ‘Understanding Ketamine’. In this vein and although our programs are open to anyone and everyone regardless of their professional background, we further prioritize active clinicians in allocating scholarships given their additional capacities to “‘bridge the gap”’ and integrate our trainings within their own communities and established clinical populations. Please be on the lookout for our upcoming fundraising events, and if you or someone you know would like to make a donation, please do so via the link below or email info@fluence8.com to discuss other ways of contributing.
| | |  | 100 Most Influential People in Psychedelics |
| PSYCHEDSTUDIO recently published a list of the 100 Most Influential People in Psychedelics, featuring Fluence co-founders Dr. Ingmar Gorman and Dr. Elizabeth Nielson. This diverse and inclusive list features individuals who have impacted the way individuals understand and engage in psychedelics. |
|
|
|
|
|
| | | FLUENCE IN THE NEWS |  | A Psychedelic Drug Passes a Big Test for PTSD TreatmentMay 3, 2021 |
|  | Psychedelic Spotlight Podcast Interview With Dr. GormanMay 25, 2021 |
|
|
|
|
|
|  | Elizabeth Nielson talks about COMPASS Pathways’ Therapist CharterApril 26, 2021 |
|
|
|
|
|
| | | Meet Our Collaborators | | | Fluence works to maintain an extensive network of collaborations with non-profits, pharmaceutical organizations, clinical services, and foundations around the world. While we have been able to announce new partnerships with several organizations, we haven’t had the opportunity to highlight all of them, until now. Under our newly launched Collaborators web page, you can now view a complete list of all of our collaborators, where you can learn more about them and how we work together to further the field of psychedelic research and medicine. | | | | |
|
|
|
